Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs Tempus AI — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.57, while Tempus AI trades at $53.26 (market cap $10.28B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| EMB | TEM | |
|---|---|---|
Sector | Fixed Income | Broad Market / Factor |
52-Week High | $97.74 | $103.25 |
52-Week Low | $91.59 | $42.37 |
Market Cap | — | $10.28B |
Enterprise Value | — | $10.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $95.625 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling sell pressure, though oscillators remain neutral. The ETF has demonstrated stable dividend distributions with recent payouts around $0.40-0.41 per share. Emerging market bond ETFs face increased institutional interest but remain sensitive to Federal Reserve policy and geopolitical risks.
The outlook for EMB hinges on emerging market sovereign debt performance amid shifting Fed rates and global risk appetite. Key opportunities include attractive yields relative to developed markets, while risks center on currency volatility and sovereign default exposure in hard currency bonds. Current technical weakness suggests cautious near-term positioning.
Tempus AI (TEM) trades at $53.69, down 8.39% over 24 hours, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth ($1.27B in 2025) and consistent earnings beats, but remains unprofitable with negative net income margins (-22.2%). Recent news highlights AI deployment in healthcare systems and FDA clearances, supporting its data-driven healthcare platform.
The outlook balances high-growth potential in AI healthcare data against persistent profitability challenges. Analyst consensus is bullish with a $68.50 price target, but investors face risks from ongoing cash burn, competitive pressures, and execution hurdles as the company scales its platform toward sustainable margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
